Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-041790

CEO and Chairman sold 30,000 shares at an average $38.47 ($1,153,965)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-15 Sale : show line 1 in the form −19,100 $38.22 $730,002 1,729,361 D
2021-06-15 Sale : show line 2 in the form −900 $39.23 $35,307 1,728,461 D
2021-06-16 Sale : show line 3 in the form −4,745 $38.13 $180,927 1,723,716 D
2021-06-17 Sale : show line 4 in the form −1,000 $38.55 $38,550 1,722,716 D
2021-06-17 Sale : show line 5 in the form −4,255 $39.76 $169,179 1,718,461 D
Open-market sales · 30,000 sh · avg $38.47 · $1,153,965
Loading xslF345X03/doc4.xml…